Compliant. Traceable. Transparent.
Update as of 25 May 2022:On 24 May 2022, the European Commission issued a legal decision confirming the suspension of the marketing authorisations of HES...
Nine new medicines recommended for approvalEMA’s human medicines committee (CHMP) recommended nine medicines for approval at its June 2022 meeting.The ...
EMA has recommended granting a conditional marketing authorisation in the European Union (EU) for Roctavian (valoctocogene roxaparvovec) for the...
EMA’s human medicines committee (CHMP) has recommended granting an extension of indication for the COVID-19 vaccine Nuvaxovid to include use in...
EMA’s human medicines committee (CHMP) has recommended granting an extension of indication for the COVID-19 vaccine Nuvaxovid to include use in...
EMA has recommended granting a marketing authorisation for COVID-19 Vaccine (inactivated, adjuvanted) Valneva for use in the primary vaccination of...
If you would like to see a demo, interested in our Beta Programme or would like to find out more information, we are happy to help.